Shanghai Biomedical Industrial Equity Investment Fund logo

Shanghai Biomedical Industrial Equity Investment Fund

Asia, Shanghai, China, Huangpu

Description

Shanghai Biomedical Industrial Equity focuses on areas that are in line with the development strategy of the biomedical industry.

Investor Profile

Shanghai Biomedical Industrial Equity Investment Fund has made 13 investments, with 5 in the past 12 months and 46% as lead.

Stage Focus

  • Series B (31%)
  • Series C (23%)
  • Series A (15%)
  • Series Unknown (15%)
  • Series D (8%)
  • Angel (8%)

Country Focus

  • China (85%)
  • Hong Kong (8%)

Industry Focus

  • Health Care
  • Medical
  • Pharmaceutical
  • Medical Device
  • Therapeutics
  • Biotechnology
  • Fitness
  • Service Industry
  • Manufacturing
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Shanghai Biomedical Industrial Equity Investment Fund frequently co-invest with?

CICC
Asia, Beijing, China, Beijing
Co-Investments: 1
MediTrust Health
Asia, Shanghai, China, Xuhui
Co-Investments: 1
GB
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 3
HC
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Co-Investments: 1
M&
North America, New York, United States, New York
Co-Investments: 1
Janchor Partners
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1

Which angels does Shanghai Biomedical Industrial Equity Investment Fund often collaborate with?

FM
North America, California, United States, Mountain View
Shared Deals: 1

What are some of recent deals done by Shanghai Biomedical Industrial Equity Investment Fund?

SaiDeDikang is a company focusing on wound management solutions

Series BFeb 18, 2025
Amount Raised: $13,736,264
Hexaell Biotech

Shanghai, Shanghai, China

Hexaell Biotech is a biopharmaceutical company focused on severe liver disease and cell therapy.

BiotechnologyHealth Care
Series BFeb 8, 2025
Amount Raised: $27,443,124
LaNova Medicines

Shanghai, Shanghai, China

LaNova Medicines is a clinical-stage innovative drug research and development company.

Health CareMedicalPharmaceutical
Series COct 18, 2024
Amount Raised: $42,242,812
Haimai Medical

Suzhou, Jiangsu, China

Haimai Medical is a platform for tissue engineering and regenerative medicine technology.

MedicalTherapeutics
Series AAug 16, 2024
PrimaNova Lab

Pingshan, Guangdong, China

Primanova, improving neurological care and outcome with physicians and patients at heart

Health CareMedical Device
Series AApr 29, 2024
Virtus Medical Holdings

Central, Hong Kong Island, Hong Kong

Virtus Medical Holdings private medical services provider.

FitnessHealth CareMedicalMedical Device
Series UnknownMar 14, 2024
Healsun Biopharm

Hangzhou, Zhejiang, China

Healsun Biopharm is a Biopharmaceutical company that focuses on antibody/recombinant protein CRO/CDMO

BiopharmaBiotechnologyHealth CarePharmaceutical
Series BAug 19, 2022
Amount Raised: $36,672,485
LaNova Medicines

Shanghai, Shanghai, China

LaNova Medicines is a clinical-stage innovative drug research and development company.

Health CareMedicalPharmaceutical
Series BJun 28, 2022
Surgerii Technology

Haidian, Beijing, China

Surgerii Technology is a developer of minimally invasive surgical robots.

Health CareMedicalRobotics
Series CJun 1, 2022
Scientech Medical

Songjiang, Shanghai, China

Scientech Medical engages in the research, development, and manufacturing of interventional medical devices.

Health CareManufacturingMedical Device
Series UnknownMay 10, 2022
Amount Raised: $14,699,987